Portfolio company
LambdaVision
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops protein-based artificial retinas in microgravity to restore vision for patients with retinitis pigmentosa and age-related macular degeneration.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neuro Modulation Artificial Retina
This company develops a high-acuity spherical bionic retinal implant to restore vision for patients with retinitis pigmentosa or age-related macular degeneration.
Pixium Vision
This company develops bionic vision restoration systems and retinal implants for patients who have lost their sight due to degenerative eye diseases.
Restore Vision
This clinical-stage biotechnology company develops visual restoration gene therapies to treat blindness caused by genetic retinal disorders for patients with retinitis pigmentosa.
CIRC Biosciences
This cell therapy company develops chemically induced retinal cells to restore vision for patients with macular degeneration and retinitis pigmentosa.
Beacon Therapeutics
This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.
Ray Therapeutics
The company develops optogenetic gene therapies to restore vision for patients with blinding retinal diseases.
Azalea Vision
This company develops smart contact lenses with integrated microelectronics to treat patients suffering from vision disorders and light sensitivity.
InGel Therapeutics
The company develops stem-cell therapies and biodegradable hydrogels for patients suffering from retinal degeneration and blinding diseases like retinitis pigmentosa.
